EnglishPharma distributor Ropharma Braşov (IAFR) increased its net profit almost five times in H1 2009, to 1.07 million lei, whereas turnover increased almost three times y/y, after its merger with three other companies.
Ropharma"s net profit in H1 2008 was 221,500 lei.
The company"s turnover grew to 131.2 million lei (31.02 million Euros), from January to June 2009, compared to 39.38 million lei in the same period of 2008, as Ropharma Braşov acquired Medica Bacău, Farmaceutica Aesculap and Global Pharmaceuticals SRL.
Ropharma Braşov has a share capital of 12.65 million lei, divided into 126.52 million shares with a face value of 0.10 lei. The company"s shareholders include Arrow Pharmaceuticals Inc. (31.31%), Rimia Investments Limited Limassol (26.63%) and Add Pharmaceuticals Ltd (23.44%). AVAS (The Authority for State Assets Recovery) holds 0.33%.
Ropharma Braşov has a market capitalization of 89.83 million lei (21.28 million Euros), according to Thursday"s price of 0.71 lei. The company is listed on the XMBS section of Rasdaq (symbol:IAFR).
Euro
Dolar SUA
Franc elveţian
Liră sterlină
Gram de aur
